FILE:BDX/BDX-8K-20121010155124.txt.gz
EVENTS:	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
TEXT:
ITEM: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
 
 
 
 
 
 
 
 
 
 
 
 
 
Check the appropriate box below if the Form 8-K Filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
 
 
 
 
 
 
On October 5, 2012, David V. Elkins, Executive Vice President and Chief Financial Officer of Becton, Dickinson and Company ("BD"), informed BD that he is resigning. Mr. Elkins' resignation is effective November 9, 2012.
Suketu Upadhyay, 43, has been named as interim Chief Financial Officer, effective November 9, 2012. Mr. Upadhyay has been serving as BD's Senior Vice President and Controller since November 2011. Prior to that, Mr. Upadhyay served as BD's Vice President of Finance  International. Before joining BD in 2010, Mr. Upadhyay was employed with AstraZeneca, serving as the Global Head of R&D Finance, and also served in various leadership roles in commercial finance. Prior to that, Mr. Upadhyay was Head of Finance for Centocor, Inc., a former subsidiary of Johnson & Johnson.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date: October 10, 2012


